Millennium Management’s Ginkgo Bioworks DNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
– Sell
-21,250
Closed -$1.54M – 6173
2023
Q3
$1.54M Buy
+21,250
New +$1.7M ﹤0.01% 3815
2023
Q2
– Sell
-12,500
Closed -$665K – 6199
2023
Q1
$665K Hold
12,500
– – ﹤0.01% 4422
2022
Q4
$845K Sell
12,500
-10,500
-46% -$966K ﹤0.01% 4327
2022
Q3
$2.87M Buy
+23,000
New +$2.74M ﹤0.01% 3434
2022
Q2
– Sell
-10,000
Closed -$1.61M – 7071
2022
Q1
$1.61M Buy
10,000
+2,500
+33% +$487K ﹤0.01% 4073
2021
Q4
$2.49M Buy
+7,500
New +$3.56M ﹤0.01% 3563

Other funds holding DNA

Millennium Management's DNA Position: Q3 2026 in Review

Millennium Management reduced its Ginkgo Bioworks (DNA) stake by 12% in Q3 2026, selling an estimated $645K and leaving 559,478 shares worth $7.18M. The position accounts for ﹤0.01% of the portfolio, ranked #2659.

Millennium Management first reported a position in DNA in Q3 2021 and has held it in 19 quarters since. The position peaked at $17.5M in Q3 2021. 185 funds tracked by Wall St. Rank hold DNA as of Q3 2026.

  • Millennium Management held 559,478 shares of Ginkgo Bioworks worth $7.18M as of Q3 2026.
  • Millennium Management sold 79,198 Ginkgo Bioworks shares in Q3 2026, an estimated $645K.
  • Ginkgo Bioworks made up ﹤0.01% of Millennium Management's portfolio in Q3 2026, its #2659 holding.
  • Millennium Management first reported a position in Ginkgo Bioworks in Q3 2021 and has held it in 19 quarters since.
  • Millennium Management's Ginkgo Bioworks position peaked at $17.5M in Q3 2021.
  • 185 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q3 2026.

Based on Millennium Management's 13F filing for Q3 2026, filed 16 Nov 2026.